Accurate blood glucose monitoring in companion animals and livestock presents a set of diagnostic challenges that differ markedly from human testing. Among the most critical — yet frequently overlooked — variables is hematocrit (HCT), the proportion of red blood cells in whole blood. When a glucose meter cannot accommodate a wide hematocrit range, readings can skew significantly, leading veterinary professionals toward misinformed treatment decisions. VivaChek, the diagnostics brand of VivaChek Biotech (Hangzhou) Co., Ltd., has developed a monitoring portfolio that directly addresses this technical gap, with glucose systems engineered to handle the physiological diversity seen across animal patients.
Why Hematocrit Range Matters in Veterinary Glucose Testing
In veterinary practice, blood hematocrit varies considerably depending on the species, age, health status, and condition of the animal being tested. Neonatal animals, pregnant livestock, and patients with anemia or polycythemia can present hematocrit values that fall well outside the ranges supported by standard glucose meters originally designed for human adult use. A device with a narrow HCT tolerance will produce unreliable readings in precisely the patients that most need accurate monitoring.
This is where the hematocrit range specification of a glucose system becomes a clinical differentiator rather than a background technical footnote. Veterinary professionals need assurance that the meter they rely on can deliver consistent, dependable results regardless of the red blood cell concentration in the sample.
VivaChek’s Veterinary-Focused Blood Glucose Monitoring System
VivaChek maintains a dedicated Veterinary product line that includes a Blood Glucose Monitoring System purpose-built for use in animal care settings, alongside a Blood Ketone Monitoring System and a Milk Ketone Monitoring System designed for dairy herd management. The existence of a fully segmented veterinary category within VivaChek’s portfolio reflects the company’s recognition that animal diagnostics carry distinct requirements that cannot be met by repurposing human-use products without technical accommodation.
The veterinary blood glucose offering operates within an ecosystem that also includes the Veterinary Coagulation and Chemistry Combo, a centrifugal microfluidic platform that delivers coagulation results in ≤15 minutes and chemistry results in ≤13 minutes, using sample volumes of 180 μL for coagulation and 140 μL for chemistry. This rapid turnaround capability supports the kind of point-of-care decision-making that is essential in busy veterinary clinics and field settings.
The VivaChek Neo System and Its 0–70% Hematocrit Range
One of the most technically significant data points across VivaChek’s glucose monitoring product line is the hematocrit range of 0–70% featured in the VivaChek Neo System. This specification means the meter can generate reliable glucose readings across an exceptionally broad spectrum of patient profiles — including neonates, pregnant patients, and individuals with anemia — categories that map directly onto the physiological variety encountered in veterinary practice.
The VivaChek Neo System is positioned as a blood glucose monitoring system designed to quantitatively measure glucose concentrations in fresh whole blood, and its wide HCT range is explicitly cited as a differentiating feature. For veterinary users evaluating glucose meters, a 0–70% hematocrit tolerance provides meaningful assurance that the device is not restricted to the narrower adult human normal range.
Key Technical Specifications of the VivaChek Neo System
- Hematocrit range: 0–70%
- Memory capacity: Up to 1,000 records with date and time
- Display screen: 40 mm × 40 mm
- Dimensions: 96 mm × 58.5 mm × 24 mm
- Battery: One CR 2032 3.0V coin cell battery
- Strip compatibility: VivaChek Neo Blood Glucose Test Strips
- Data connectivity: Optional Auto Sync Bluetooth for seamless data transfer to compatible devices
The optional Bluetooth synchronization feature is particularly relevant in modern veterinary practice, where digital record-keeping and integration with practice management software represent a growing standard of care. The ability to store 1,000 timestamped test results supports longitudinal tracking of a patient’s glycemic trends without requiring manual transcription.
Multi-Function Monitoring and the VivaChek X System
For veterinary professionals seeking expanded metabolic insight beyond glucose alone, the VivaChek X multi-function monitoring system offers a three-in-one platform capable of testing glucose, ketone, and uric acid levels from a single device. This consolidation reduces the number of instruments required at a practice and simplifies the workflow for point-of-care metabolic assessment.
VivaChek X Specifications Relevant to Veterinary Use
- Memory: 1,000 results with time and date
- Display: 37 mm x 47 mm
- Battery: Two AAA LR03 1.5V batteries
- Data transfer: Optional Bluetooth
- Strip compatibility: VivaChek Ino Blood Glucose, VivaChek Fad Blood Glucose, VivaChek Blood Ketone, and VivaChek Uric Acid Test Strips
- Strip ejector: Reduces contamination risk by eliminating direct contact with used strips — a hygiene consideration relevant in clinical environments handling multiple patients
The inclusion of a strip ejector reflects an understanding of real-world workflow in busy diagnostic settings, where minimizing cross-contamination is a practical concern.
Quality Assurance and Regulatory Certifications
VivaChek Biotech’s quality management system aligns with a comprehensive set of international regulatory standards, providing veterinary distributors and institutional buyers with a documented quality foundation. Applicable certifications include:
- FDA 510(k) clearance
- European Union CE marking
- China NMPA registration
- EN ISO 13485 certification
- China GMP compliance
- FDA QSR (Quality System Regulations)
- DIN EN ISO 15197:2013 compliance for the VivaChek Ino and VivaChek Eco glucose meters
Manufacturing operations are based in Shaoxing, Zhejiang Province, with the corporate headquarters located in Hangzhou, Zhejiang, People’s Republic of China. This established manufacturing infrastructure supports consistent product quality across the full portfolio.
Global Reach and Market Validation
Founded in August 2013, VivaChek Biotech has expanded its distribution footprint to reach over 120 countries as of the present date. Within approximately one year of initial product launch, VivaChek glucose meters had already reached more than 30 countries, a trajectory that reflects structured international commercialization. The company’s blood glucose meters have, over time, helped millions of diabetic patients worldwide manage their condition — a scale of deployment that provides real-world validation of device reliability.
The company’s international infrastructure includes entities and branches in the United States (both in Sacramento, California and Wilmington, Delaware), India (Chennai), and Singapore, supporting regional distribution and regulatory engagement across major markets.
Considerations for Veterinary Procurement
For veterinary practices, diagnostic labs, and distributors evaluating pet glucose monitors with wide hematocrit range capability, the following VivaChek system attributes warrant particular attention:
- The 0–70% HCT range of the VivaChek Neo System accommodates the full physiological diversity of animal patients
- Biosensor technology underpins the glucose, ketone, and uric acid measurement capabilities across the product line
- The optional Bluetooth data transfer function supports digital record integration
- The centrifugal microfluidic platform in the Veterinary Coagulation and Chemistry Combo enables rapid coagulation and chemistry results from small-volume samples
- A broad certifications portfolio provides regulatory confidence for buyers in multiple markets
VivaChek’s development concept of "making health management accessible" extends, through its veterinary product line, to the goal of delivering reliable, easy-to-use diagnostic tools that support accurate point-of-care decision-making in animal care environments. The combination of wide hematocrit tolerance, multi-parameter capability, and an internationally validated quality system positions VivaChek’s glucose monitoring portfolio as a technically substantive option for veterinary diagnostic applications.
https://www.vivachek.com
Hangzhou Weice Biotech Co., Ltd.
